"Republicans Urged to Target Biden on Drug Pricing Amid Medicare Negotiations"

Republican strategists are seeking to counter President Joe Biden's drug pricing plan by framing it as stifling innovation and leading to price controls. They argue that the negotiations process can harm clinical programs and restrict the development of new treatments. However, Democrats are confident in their ability to run on the issue, with a recent poll showing that a majority of independent voters trust them to lower drug costs. Republicans are still searching for a clear alternative plan that resonates with voters and stands in contrast to the Democrats' approach.